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IntroductIon
Salvia officinalis L. (Lamiaceae), known as Dalmatian 
sage, is a perennial subshrub native to the northern 
coastal region of the Mediterranean and grows wild in 
central Spain, southern France and the western part of 
the Balkan Peninsula (Hedge, 1972). Dalmatian sage is an 
official drug in most pharmacopoeia, and chemical varia-
tions of its essential oils were investigated depending on 
the origin, ecological conditions and different stages of 
plant development (Perry et al., 1999; Santos-Gomes and 
Fernandes-Ferreira, 2001; Marić et al., 2006; Bernotienė 
et al., 2007; Maksimović et al., 2007; Ben Farhat et al., 
2009; Jug-Dujakovic et al., 2012; Lakušić et al., 2013).
The wide spread of multidrug-resistant (MDR) 
bacteria is documented as a serious problem that af-
fects the choice of appropriate antibiotic therapy and 
increases the probability of unfavorable infection 
outcome. Resistance to all classes of antibiotics has 
emerged, leading to a continuous need to produce 
new drugs. One promising method in coping with 
bacterial resistance is the use of alternative classes of 
antimicrobial agents and the application of the syner-
gistic activity between antibiotics, and between anti-
biotics and non-antibiotics (Kalan and Wright, 2011).
In recent years, methicillin-resistant Staphylo-
coccus aureus (MRSA) has emerged as a major pub-
lic health concern worldwide (Kennedy et al., 2008; 
DeLeo et al., 2010). This important nosocomial and 
community-acquired pathogen has developed resis-
tance to various antibiotics (β-lactams, quinolones and 
aminoglycosides). Since infections caused by  MRSA
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abstract: Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) due to the acquisition of resistance to 
current antimicrobials pose a serious challenge for therapy, and new measures to treat and prevent this infectious patho-
gen are of crucial importance. Plant essential oils (EOs) and their constituents are promising agents with antimicrobial 
properties. The aim of this study was to evaluate the antistaphylococcal effect of essential oils from Salvia officinalis using 
the broth-microdilution method. Essential oils of S. officinalis were isolated from the same individual, but at different life 
stages – young and old leaves. The effects of combinations of sub-inhibitory concentrations of oil and different antibiotics 
were evaluated by the checkerboard method. The results, expressed as the fractional inhibitory concentration (FIC) and 
index (FICI), indicate that the essential oil isolated from young leaves potentiated the inhibitory effect of antibiotics against 
tested MRSA strains.
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1 cis-Salvene 855 0.3 0.3
2 trans-Salvene 861 0.0 0.1
3 Tricyclene 921 0.0 0.1
4 α-Thujene 927 0.3 1.1
5 α -Pinene 933 1.9 0.7
6 Camphene 947 1.2 3.6
7 Sabinene 969 0.4 0.9
8 β-Pinene 975 6.5 0.3
9 Myrcene 994 0.8 1.2
10 α-Phellandrene 1005 0.0 0.2
11 α -Terpinene 1018 0.1 1.5
12 p-Cymene 1026 0.3 2.0
13 Limonene 1029 1.0 2.6
14 1,8-Cineole 1031 19.4 2.5
15 cis-β-Ocimene 1035 0.3 0.0
16 trans- β-Ocimene 1045 0.1 0.0
17 γ-Terpinene 1060 0.4 2.9
18 cis-Sabinene hydrate 1070 0.4 1.0
19 Terpinolene 1089 0.2 0.9
20 trans-Sabinene hydrate 1101 0.8 1.8
21 cis-Thujone 1107 16.5 25.9
22 trans-Thujone 1118 2.4 4.3
23 α-Campholenal 1124 0.0 0.2
24 trans-Sabinol 1137 0.1 0.1
25 Camphor 1145 10.7 30.4
26 trans-Pinocamphone 1163 0.2 0.2
27 Borneol 1167 1.9 0.6
28 cis-Pinocamphone 1172 0.0 1.8
29 Terpinen-4-ol 1180 0.3 0.1
30 α-Terpineol 1195 0.2 0.1
31 Bornyl acetate 1288 0.4 0.4
32 trans-Sabinyl acetate 1289 0.0 0.1
33 β-Caryophyllene 1420 1.2 0.4
34 α-Humulene 1455 16.2 4.5
35 γ-Muurolene 1478 0.0 0.1
36 Viridiflorene 1496 0.1 0.0
37 Caryophyllene oxide 1583 0.2 0.1
38 Viridiflorol 1592 2.9 3.3
39 Humulene epoxide I 1593 0.4 0.2
40 Humulene epoxide II 1609 2.4 1.1
41 n.i. n/a 0.1 0.3
42 n.i. n/a 0.0 0.2
43 Manool 2056 9.0 2.0
44 n.i. n/a 0.4 0.1
Total 100 100
KIE = Kovats (retention) index experimentally determined (AM-
DIS); n.i.=not identified
are increasing, as are rates of antibiotic therapy fail-
ure, alternative strategies need to be found to treat 
and prevent these infections. A possible solution may 
be to combine existing antibiotics with phytochemi-
cals to enhance the efficacy of antibiotics. A group of 
phytochemicals that is said to have such effects, ac-
cording to in vitro studies, is essential oils (EOs) and 
their components (Kon and Rai, 2012). 
The aims of our study were to examine the anti-
microbial effect of the essential oil of Dalmatian sage 
(Salviae aetheroleum) from different stages of leaf de-
velopment and combined application of the essential 
oil with the best antimicrobial effect and various anti-
biotics on the growth of methicillin-resistant Staphy-
lococcus aureus strains (MRSA). 
MaterIaLS and MethodS
Plant material 
Salvia officinalis from Učka in Croatia was success-
fully grown for ten years in a private garden in Bel-
grade (Serbia). Two samples of essential oils were 
analyzed: essential oil from young leaves (sample A 
– SalOff-102) and from old leaves (sample B - Sal-
Off-109). In the research, essential oil of sage pro-
duced by Kirka producer (sample C) was used.
oil isolation 
Oils were isolated from fresh material, always using 
the same distillation apparatus under the same condi-
tions. The essential oils were isolated by hydrodistil-
lation, according to the standard procedure reported 
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bacterial strains and susceptibility testing
Antibacterial activity of essential oils was tested 
against four clinical isolates of MRSA and one labo-
ratory control strain of methicillin-resistant S. aureus 
ATCC 43300 (KWIK-STIKTM, Microbiologics, USA) 
as a positive control. MRSA strains were isolated from 
wound (Strain No 5), blood (Strains No 6 and 7) and 
endotracheal tube (Strain No 8). Identification of the 
isolates and methicillin resistance were firstly deter-
mined by VITEK 2 automated system (VITEK 2 test 
cards GP and AST-P580; bioMérieux, France). All 
tested strains were identified as Staphylococcus aureus 
(with 98.57-99.00% level of confidence) and expressed 
resistance to methicillin. Furthermore, identification 
and methicillin resistance were confirmed by PCR for 
the nuc gene that encodes the thermostable nuclease 
of Staphylococcus aureus (Brakstad et al., 1992) and 
mecA gene that encodes the penicillin-binding pro-
tein PBP2’ specific for MRSA strains (Bignardi et al., 
1996). All tested strains were nuc- and mecA-positive. 




MrSa strain no a b c ctX cIP gen
5 25 >400 >400 32 1.0 2.0
6 25 >400 400 32 0.5 2.0
7 >400 >400 >400 64 8.0 16.0
8 25 >400 400 64 0.2 0.5
ATCC 43300 25 >400 >400 32 16.0 256.0
* CTX-ceftriaxone, CIP-ciprofloxacin and GEN-gentamicin
The antimicrobial activity of essential oils was 
determined by broth-microdilution test according to 
Clinical and Laboratory Standards Institute guide-
lines (CLSI, 2007). Briefly, essential oils were diluted 
to the desired concentrations (ranging from 3.12-400 
μg/ml) with fresh Mueller-Hinton broth (MHB) with 
the addition of 0.05% triphenyl tetrazolium chloride 
(TTC) (Sigma-Aldrich) as a growth indicator, set in 
triplicate and inoculated with 5x105 CFU/ml of bac-
teria. After incubation for 24 h at 35°C in aerobic 
in the Sixth European Pharmacopoeia (2007) using 
a Clevenger-type apparatus. Duration of distillation 
was 2 h. Oil samples were dissolved in ethanol and 
analyzed by gas chromatography/flame ionization 
detector (GC/FID) and gas chromatography/mass 
spectrometry (GC/MS). 
analytical gas chromatography (gc/fId)
GC/FID analysis of the oils was carried out on a HP-
5890 Series II GC (Hewlett-Packard, Waldbronn, 
Germany), equipped with split-splitless injector and 
automatic liquid sampler (ALS), attached to an HP-5 
column (25 m; 0.32 mm; 0.52 μm film thickness) and 
fitted to a flame ionization detector (FID). Carrier 
gas flow rate (H2) was 1 ml/min, split ratio 1:30, with 
injector temperature 250°C, detector temperature 
300°C, while the column temperature was linearly 
programmed from 40-260°C (at 4°/min). Solutions 
of essential oil samples in ethanol (~1%) were con-
secutively injected by ALS (1 μl, split mode 1:30). 
Area percent reports, obtained from the standard 
processing of chromatograms, were used as a basis 
for quantification. 
gas chromatography/mass spectrometry (gc/MS)
The same analytical conditions as those mentioned for 
GC/FID were used for GC/MS analysis, along with an 
HP-5MS column (30 m; 0.25 mm; 0.25 μm film thick-
ness), using an HP G 1800C Series II GCD system 
(Hewlett-Packard, Palo Alto, CA, USA). Instead of hy-
drogen, helium was used as carrier gas. The transfer line 
was heated at 260°C. Mass spectra were acquired in EI 
mode (70 eV), in the range of 40-450 m/z. Sample solu-
tions in ethanol (~1 %) were injected by ALS (200 nl, 
split mode 1:30). The components of the oil were iden-
tified by comparison of their mass spectra with those 
from Wiley275 and NIST/NBS libraries, using different 
search engines. The experimental values for retention 
indices were determined by the use of calibrated Au-
tomated Mass Spectral Deconvolution and Identifica-
tion System software (AMDIS ver.2.1.), compared with 
those from available literature (Adams, 2007) and used 
as an additional tool to confirm the MS findings.
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conditions, minimum inhibitory concentrations 
(MIC) were determined. TTC is a redox indicator 
used for differentiation between metabolically ac-
tive and non-active cells. The colorless compound is 
enzymatically reduced to red 1,3,5-triphenylforma-
zan by bacterial dehydrogenases, indicating bacterial 
metabolic activity (i.e. red color of the microtiter plate 
well). MIC values were determined as the lowest con-
centration of essential oil or antibiotic that inhibited 
bacterial growth (i.e., wells with unchanged-yellow 
color of medium). Each broth-microdilution test was 
repeated three times.
Synergy testing
The synergism between essential oils and commercial 
drugs was investigated by the checkerboard method 
according to White et al. (1996). Three antibiotics 
representing different groups of antimicrobial agents 
were used: β-lactam ceftriaxone (CTX) and non 
β-lactam antibiotics, ciprofloxacin (CIP) and genta-
micin (GEN) (Sigma-Aldrich). The synergistic effect 
of combinations was investigated in one concentra-
tion above and several concentrations below the MIC 
of each compound (both antibiotic and tested essen-
tial oil). The test was performed in 96-well microtiter 
plates as a modified broth-microdilution test. Essen-
tial oils and antibiotics were diluted to the desired 
concentrations with MHB with the addition of 0.05% 
TTC. The combination of essential oils and antibiot-
ics was prepared by adding 50 µl of each to the same 
well of microtiter plate, and inoculating with 100 
µl of previously prepared bacteria (5x105 CFU/ml). 
After incubation for 24 h at 35°C in aerobic condi-
tions, the MIC of the combination was determined. 
The interaction between the two antimicrobial agents 
was estimated by calculating the fractional inhibitory 
concentration (FIC) indices (FICI). The FIC of each 
compound was calculated by dividing the concentra-
tion of the compound in effective MIC of the com-
bination with the MIC of the drug alone (e.g. FICes-
sential oil = MICessential oil-antibiotic combination/MICessential oil). FICI 
values were calculated as the sum of the FICessential oil 
and FICantibiotic and interpreted as following: FICI ≤ 0.5 
synergy; 0.5 < FICI ≤ 1 additivity; 1 < FICI ≤ 2 indif-
ference (no effect) and FICI ≥ 2 antagonism (Hu et 
al., 2002; Orhan et al., 2005). Each test was repeated 
three times.
reSuLtS 
Leaves of the same plant of S. officinalis at different 
stages of development form different types of oil 
(Lakušić et al., 2013). In the essential oil of young 
leaves (sample A – SalOff-102) 1,8 cineole (19.4%), 
cis-thujone (16.5%), α-humulene (16.2%), camphor 
(10.7%) and manool (9.0%) were dominant, whereas 
in the oil of the old leaves (sample B - SalOff-109) 
cis-thujone (25.9%) and camphor (30.4%) were dom-
inant (Table 1).
The antimicrobial effect of the essential oils 
against MRSA was observed only with sample A (Sa-
lOff-102). Certain MIC values of oil A were almost 
identical for most strains and amounted to 25 μg/ml, 
except for hospital strain No. 7, which proved to be 
completely resistant. Sample B (SalOff-109) did not 
show antimicrobial effect. The commercial oil (sam-
ple C) showed antimicrobial activity only on MRSA 
strains No 6 and 8, at high concentration (Table 2). 
The MIC values of antibiotics were in the range of 
32-64 μg/ml (CTX), 0.2-16 μg/ml (CIP) and 0.5-256 
μg/ml (GEN). All tested MRSA strains were resistant 
to ceftriaxone (MIC > 4 µg/ml), two strains to cipro-
floxacin (MIC > 1 µg/ml) and four strains to genta-
micin (MIC > 1 µg/ml) (EUCAST 2014). The MICs 
of the antibiotics are presented in Table 2.
The checkerboard method was performed with 
three antibiotics that represent different groups of 
antimicrobial agents: β-lactam antibiotic-cephalo-
sporins (CTX), fluoroquinolone (CIP) and amino-
glycoside (GEN). The overall effect of essential oil-
antibiotic combinations varied from synergistic (FICI 
≤ 0.5) to antagonistic (FICI ≥ 2). The most significant 
synergistic effect was observed in the combination 
of essential oil A and ceftriaxone and ciprofloxacin 
against all tested strains of MRSA. The effects were 
exhibited in essential oil A/CTX combinations at 
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concentration of 1/16 MIC (1.56 μg/ml) of essen-
tial oil A and 1/8-1/4 MIC (8 μg/ml) of CTX, and in 
essential oil A/CIP combinations at a concentration 
of 1/16 MIC (1.56 μg/ml) of essential oil A and 1/128-
1/2 MIC (0.125 μg/ml) of CIP. The results of in vitro 
activity of tested oil in combination with conventional 
antibiotics are given in Table 3 and Fig. 1. The most 
prevalent synergistic interaction was noted when 
Salviae aetheroleum was combined with ceftriaxone 
(FICI: 0.312-0.453) and ciprofloxacin (FICI: 0.070-
0.562); when combined with gentamicin, an antago-
nistic interaction was noted (Strain No 6, FICI 2.125). 
It is interesting that the same combination of essen-
tial oil and gentamicin exhibited synergistic effect on 
other MRSA strains.
dIScuSSIon
Considering that the essential oil of young leaves 
(sample A) contains a significant amount of 1,8-cin-
eole, α-humulene, manool, camphor and cis-thujone, 
it may be assumed that these components play a cru-
cial role in the antimicrobial activity of the oil. On 
the other hand, the essential oil of old leaves (sample 
B) did not show antimicrobial effect against MRSA, 
although it contains a significantly higher amount of 
cis-thujone and camphor, which could indicate that 
camphor and cis-thujone do not inhibit the growth 
of MRSA. However, it is most probable that the dif-
ferent antibacterial activity exhibited by the oils is the 
result of the synergistic effect of the all components 
in the oil, even those that are present in minimal 
concentration. 
The emergence of multi-drug resistant micro-
bial strains is becoming a formidable threat in the 
fight against infective diseases. Thus, alternatives to 
the standard treatments with single agents are pres-
ently being sought. Generally, the combined use of 
antimicrobial agents can potentially increase over-
all antimicrobial activity and reduce toxicity of both 
agents towards human cells (Kon and Rai, 2012; 
Verma, 2007).
Different combinations of EOs and traditional 
antibiotics demonstrated an enhancing effect, which 
is important in restoring the activity of inactive anti-
biotics and prolonging the activity of presently highly 
efficient drugs. Combinations of essential oils with 
conventional antibiotics could be an effective alterna-
tive in the treatment of infections caused by MRSA. 
Essential oils of Zataria multiflora demonstrated 
high activity against clinical isolates of MRSA and 
methicillin-susceptible S. aureus (MSSA), but also 
enhanced the activity of vancomycin (Mahboubi and 
Bidgoli, 2010).
In a study conducted by Rosato et al. (2010), the 
effect of combinations of gentamicin and four EOs 
(Aniba rosaeodora, Melaleuca alternifolia, Origanum 
vulgare and Pelargonium graveolens) was evaluated by 
the checkerboard method against several reference 
bacterial strains. A synergistic effect against all tested 
fig. 1. FICI values of the essential oil A/antibiotic combination. A/CTX (ceftriaxone); A/CIP (ciprofloxacin) and A/GEN (gentamicin). 
FICI ≤ 0.5 synergy; 0.5 < FICI ≤ 1 additivity and FICI ≥ 2 antagonism.
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strains was observed in gentamicin/A. rosaeodora and 
gentamicin/P. graveolens combinations, while in the 
other two combinations the effect was from synergis-
tic to indifferent.
It should be noted that whether an essential oil 
with known antimicrobial activity will produce ben-
eficial or harmful effects when combined with con-
ventional antimicrobials depends on the ratio of the 
two components. Van Vuuren et al. (2009) studied the 
activity of four EOs (Melaleuca alternifolia, Thymus 
vulgaris, Mentha piperita and Rosmarinus officinalis) 
in combination with ciprofloxacin against S. aureus 
and Klebsiella pneumoniae in nine different ratios. 
The study demonstrated the presence of concentra-
tion-dependent interactions between EOs and anti-
biotics: the same EO showed effects from synergistic 
to antagonistic when combined with ciprofloxacin 
depending on the ratios of both agents.
It is worth emphasizing that although many EOs 
and their components have a high level of antibacte-
rial activity (Lorenzi et al., 2009; Si et al., 2008), pre-
cautions should be taken because of the presence of a 
rather large number of antagonistic interactions (van 
Vuuren et al., 2009) that should not be ignored (van 
Vuuren and Viljoen, 2011).
Our preliminary study demonstrated the presence 
of different interactions between Salvia officinalis 
essential oil and antibiotics: the same combination 
showed different effects, from synergistic to antago-
nistic, on different clinical isolates of MRSA. These 
findings demonstrate the necessity for systematic in 
vitro studies of interactions of EOs and antibiotics to 
reveal any undesirable combinations. Combinations 
of EOs with antibiotics should only be chosen for 
treatment when synergistic or additive interactions 
are documented. The main limitation of this study 
was small number of both MRSA strains and anti-
biotics tested. Having this in mind, in future we will 
include some additional MRSA strains and antibiotics 
in our research. In addition, essential oil characteris-
tics need to be monitored throughout the develop-
ment of plants, because it is evident that the oil iso-
lated at different stages of development has different 
antimicrobial activity.
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table 3. The in vitro activity of essential oil in combination with conventional antibiotics against MRSA.
a/ctX a/cIP a/gen
Strain no MIc (µg/ml) eff MIc (µg/ml) eff MIc (µg/ml) eff
5 1.56/8 syn 1.56/0.125 syn 1.56/0.25 syn
6 1.56/8 syn 1.56/0.125 syn 3.12/4 ant
7 >12.5/128 / >12.5/2 / >12.5/4 /
8 1.56/8 syn 1.56/0.125 add 1.56/0.25 add
ATCC43300 1.56/8 syn 1.56/0.125 syn >12.5/4 /
*CTX-ceftriaxone, CIP-ciprofloxacin and GEN-gentamicin. Effect (eff): synergy (syn), additivity (add) and antagonism (ant).
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